A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066

Mise à jour : Il y a 4 ans
Référence : NCT01130493

Femme et Homme

Extrait

This is a study to compare the efficacy of IPX066 and CLE in subjects with advanced Parkinson's disease.


Critère d'inclusion

  • Parkinson's disease


Liens